The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
about
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsCannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceThe endocannabinoid system as an emerging target of pharmacotherapyHuman cannabinoid pharmacokineticsIs the cardiovascular system a therapeutic target for cannabidiol?Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritisCurrent Therapeutic Cannabis Controversies and Clinical Trial Design IssuesMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideThe synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic painVirtualizing the p-ANAPL library: a step towards drug discovery from African medicinal plantsProtective effects of cannabidiol on lesion-induced intervertebral disc degenerationCannabis and Cannabis ExtractsCannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development.A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cellsMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Cannabinoids as novel anti-inflammatory drugs.Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiolTransdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosisCannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy.Therapeutic potential of anti-inflammatory drugs in focal stroke.Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusionPathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.Cannabidiol: an overview of some pharmacological aspects.The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and massTaste avoidance and taste aversion: evidence for two different processes.Anxiogenic-like effects of chronic cannabidiol administration in rats.Effects of cannabidiol (CBD) on regional cerebral blood flow.Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity.Therapeutic potential of cannabinoid medicines.Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.The Pharmacological Basis of Cannabis Therapy for Epilepsy.Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.Cannabinoid control of neuroinflammation related to multiple sclerosis.Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's diseaseInhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
P2860
Q24322122-DE39E14E-3ED5-4866-81B8-5664828A2DAEQ24606148-360E8D07-C8B1-4CED-863C-0FAE53EFE22FQ24645241-862E293A-BA85-41DC-A07E-27A7FFB00C9BQ24648473-7E1232F1-1724-4D9B-9D33-2E89F6A60F7DQ24652736-03951C67-C499-455E-AC88-4EBD3837C925Q26865370-2F6C4839-49FD-48AB-94AD-DD35E2B02434Q27322469-D3AF6835-486E-442D-9B4A-ADB2BB5A4C8DQ28071794-06D13411-81A3-4BB9-BA42-87B8FA9E6197Q28362078-CC6EEC06-B13C-4E9B-B91A-3D68691D690CQ28366593-51FFC0E4-CC46-4B3F-9B5C-5CE73F565E68Q28540495-A4337F1A-E6F6-43DD-8AC6-818630D7CC73Q28542740-1B28C43F-897C-4DB5-BED8-2D0C010C8E67Q30040327-2C7FDA79-AD87-4684-B058-2DEE03A7FE4BQ30497010-29CE6F29-AF3B-4DEE-8618-C8346353B829Q30670447-50BF64F9-E32F-4C36-B3DD-3655B457E940Q33581824-72E0EB1C-7C2E-4E64-A20D-8978DCF9CCFDQ33636763-7A6E154D-2B7C-42CC-A76D-E1B44872ADFDQ33688381-0196E745-AEFC-469D-ABC1-8B6CCE3C74D3Q33690796-6B6CE261-7906-4C41-BD53-0B3578B4FF04Q33869556-4CB2393A-BA70-4561-84F1-51E99CB12705Q33897251-0ABFC315-3A68-4288-878A-D42DC1B73A70Q33947213-377D5DCC-F06D-430B-BA76-EF163F494ECDQ33959167-B1C5DC3A-253B-4D06-8011-4C5BA912927AQ34075110-A67828A0-1E4D-47DD-97F8-AF684869F47FQ34113027-98E19A99-EEB9-4A42-BA5E-C7D3BEAC191BQ34139377-681DE1C9-2A8E-4AE6-94EF-2614147420E7Q34157378-4229A060-EB62-4C2D-8120-243F1908F125Q34181605-80DC9E2B-EEB6-42D7-B60E-3008ACD7B027Q34199882-304C7BB4-5051-4599-9DCA-B2B4FAC7F37EQ34217248-71541B35-E45A-4BDD-9457-4E11DFFF6B92Q34232627-8E674F47-DB9D-4BA7-8A6F-67E60152DDFAQ34272906-B13B9F1B-E005-4805-A71B-5D5F5FC70C50Q34280435-CFB1680A-88C5-4209-A47D-AA123E843BF5Q34368715-266EDD58-4B52-4E40-99D0-ED5441F89A94Q34402827-B8D450DD-97CB-43CF-8057-F049BB13F011Q34509920-515EEC01-FB00-4B09-9C80-EF3F79AA8BDBQ34519365-C6DD70A0-2477-4449-AFBE-9ABBC4B41A5DQ34583231-94C8F881-E5EA-43CF-BF0E-870D42B0A858Q34627188-791E3039-98E3-4F0C-987A-4B9529F21111Q34651059-B2E18A67-2D8F-4F45-885C-282CFF96DF19
P2860
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@ast
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@en
type
label
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@ast
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@en
prefLabel
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@ast
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@en
P2093
P2860
P356
P1476
The nonpsychoactive cannabis c ...... ine collagen-induced arthritis
@en
P2093
A M Malfait
E Andreakos
M Feldmann
P F Sumariwalla
P2860
P304
P356
10.1073/PNAS.160105897
P407
P577
2000-08-01T00:00:00Z